Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase on the organ injury and dysfunction caused by haemorrhagic shock

被引:84
作者
McDonald, MC
Mota-Filipe, H
Wright, JA
Abdelrahman, M
Threadgill, MD
Thompson, AS
Thiemermann, C
机构
[1] St Bartholomews & Royal London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England
[2] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England
关键词
5-aminoisoquinolinone; haemorrhagic shock; oxygen radicals; poly (ADP-ribose) synthetase; multiple organ failure; trauma;
D O I
10.1038/sj.bjp.0703391
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Poly (ADP-ribose) synthetase (PARP) is a nuclear enzyme activated by strand breaks in DNA, which are caused inter alia by reactive oxygen species (ROS). Here we report on (i) a new synthesis of a water-soluble and potent PARP inhibitor, 5-aminoisoquinolinone (5-AIQ) and (ii) investigate the effects of 5-AIQ on the circulatory failure and the organ injury/dysfunction caused by haemorrhage and resuscitation in the anaesthetized rat. 2 Exposure of human cardiac myoblasts (Girardi cells) to hydrogen peroxide (H2O2, 3 mM for 1 h, n = 9) caused a substantial increase in PARP activity. Pre-treatment of these cells with 5-AIQ (1 mu M - 1 mM, 10 min prior to H2O2) caused a concentration-dependent inhibition of PARP activity (IC50: similar to 0.01 mM, n = 6). 3 Haemorrhage and resuscitation resulted (within 4 h after resuscitation) in a delayed fall in blood pressure (circulatory failure) as well as in rises in the serum levels of (i) urea and creatinine (renal dysfunction), (ii) aspartate aminotransferase (AST), alanine aminotransferase (ALT), and gammaglutamyl-transferase (gamma-GT) (liver injury and dysfunction), (iii) lipase (pancreatic injury) and (iv) creatine kinase (CK) (neuromuscular injury) (n = 10). 4 Administration (5 min prior to resuscitation of 5-AIQ) (0.03 mg kg(-1) i.v., n = 8, or 0.3 mg kg(-1) i.v., n = 10) reduced (in a dose-related fashion) the multiple organ injury and dysfunction? but did not affect the circulatory failure, associated with haemorrhagic shock. 5 Thus, 5-AIQ abolishes the multiple organ injury caused by severe haemorrhage and resuscitation.
引用
收藏
页码:843 / 850
页数:8
相关论文
共 34 条
[21]   OXIDANT INJURY OF CELLS - DNA STRAND-BREAKS ACTIVATE POLYADENOSINE DIPHOSPHATE-RIBOSE POLYMERASE AND LEAD TO DEPLETION OF NICOTINAMIDE ADENINE-DINUCLEOTIDE [J].
SCHRAUFSTATTER, IU ;
HINSHAW, DB ;
HYSLOP, PA ;
SPRAGG, RG ;
COCHRANE, CG .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (04) :1312-1320
[22]  
SOMEI M, 1981, CHEM PHARM BULL, V29, P249
[23]  
SUTO MJ, 1991, ANTI-CANCER DRUG DES, V6, P107
[24]   3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, improves hemodynamics and prolongs survival in a porcine model of hemorrhagic shock [J].
Szabó, A ;
Hake, P ;
Salzman, AL ;
Szabó, C .
SHOCK, 1998, 10 (05) :347-353
[25]   Potential role of the peroxynitrite-poly(ADP-ribose) synthetase pathway in a rat model of severe hemorrhagic shock [J].
Szabó, C .
SHOCK, 1998, 9 (05) :341-344
[26]   THE MULTIPLE ORGAN DYSFUNCTION SYNDROME CAUSED BY ENDOTOXIN IN THE RAT - ATTENUATION OF LIVER DYSFUNCTION BY INHIBITORS OF NITRIC-OXIDE SYNTHASE [J].
THIEMERMANN, C ;
RUETTEN, H ;
WU, CC ;
VANE, JR .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (07) :2845-2851
[27]   Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle [J].
Thiemermann, C ;
Bowes, J ;
Myint, FP ;
Vane, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (02) :679-683
[28]   REACTIVE OXYGEN INJURY TO CULTURED PULMONARY-ARTERY ENDOTHELIAL-CELLS - MEDIATION BY POLY(ADP-RIBOSE) POLYMERASE ACTIVATION CAUSING NAD DEPLETION AND ALTERED ENERGY-BALANCE [J].
THIES, RL ;
AUTOR, AP .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1991, 286 (02) :353-363
[29]  
UEDA K, 1985, ANNU REV BIOCHEM, V54, P73, DOI 10.1146/annurev.bi.54.070185.000445
[30]   Synthesis of 3-substituted benzamides and 5-substituted isoquinolin-1(2H)-ones and preliminary evaluation as inhibitors of poly(ADP-ribose)polymerase (PARP) [J].
Watson, CY ;
Whish, WJD ;
Threadgill, MD .
BIOORGANIC & MEDICINAL CHEMISTRY, 1998, 6 (06) :721-734